USANA Health Sciences Inc (USNA) - Total Liabilities
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has total liabilities worth $144.18 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check USANA Health Sciences Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
USANA Health Sciences Inc - Total Liabilities Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is USANA Health Sciences Inc's balance sheet.
USANA Health Sciences Inc Competitors by Total Liabilities
The table below lists competitors of USANA Health Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
|
China | CN¥1.09 Billion |
|
COG Financial Services Ltd
AU:COG
|
Australia | AU$536.47 Million |
|
TSC Auto ID Technology Co Ltd
TWO:3611
|
Taiwan | NT$7.28 Billion |
|
i3 Verticals Inc
NASDAQ:IIIV
|
USA | $226.65 Million |
|
National Bankshares Inc
NASDAQ:NKSH
|
USA | $1.64 Billion |
|
Invesco Municipal Income Opportunities Closed Fund Class Common
NYSE:OIA
|
USA | $130.85 Million |
|
Fiera Capital Corporation
TO:FSZ
|
Canada | CA$956.48 Million |
|
Nuveen Core Plus Impact Fund
NYSE:NPCT
|
USA | $184.42 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down USANA Health Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See USNA net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how USANA Health Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for USANA Health Sciences Inc (1995–2025)
The table below shows the annual total liabilities of USANA Health Sciences Inc from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $156.64 Million | -3.22% |
| 2024-12-31 | $161.86 Million | +19.41% |
| 2023-12-31 | $135.56 Million | -16.36% |
| 2022-12-31 | $162.08 Million | -11.25% |
| 2021-12-31 | $182.62 Million | -8.34% |
| 2020-12-31 | $199.24 Million | +20.59% |
| 2019-12-31 | $165.22 Million | +1.17% |
| 2018-12-31 | $163.32 Million | +4.65% |
| 2017-12-31 | $156.06 Million | +7.36% |
| 2016-12-31 | $145.35 Million | +2.09% |
| 2015-12-31 | $142.38 Million | +18.24% |
| 2014-12-31 | $120.42 Million | +11.55% |
| 2013-12-31 | $107.95 Million | +31.99% |
| 2012-12-31 | $81.78 Million | +15.86% |
| 2011-12-31 | $70.59 Million | +20.38% |
| 2010-12-31 | $58.64 Million | +19.51% |
| 2009-12-31 | $49.06 Million | -45.93% |
| 2008-12-31 | $90.74 Million | +28.72% |
| 2007-12-31 | $70.49 Million | +77.09% |
| 2006-12-31 | $39.80 Million | +42.31% |
| 2005-12-31 | $27.97 Million | +17.42% |
| 2004-12-31 | $23.82 Million | +14.77% |
| 2003-12-31 | $20.76 Million | -1.26% |
| 2002-12-31 | $21.02 Million | +0.93% |
| 2001-12-31 | $20.83 Million | -7.92% |
| 2000-12-31 | $22.62 Million | -5.36% |
| 1999-12-31 | $23.90 Million | +154.26% |
| 1998-12-31 | $9.40 Million | +32.39% |
| 1997-12-31 | $7.10 Million | -18.39% |
| 1996-12-31 | $8.70 Million | +141.67% |
| 1995-12-31 | $3.60 Million | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more